Company Overview and News
Income investors generally look for high-dividend stocks and low risk. But that’s a difficult combination to find. Dividend yields can rise if the dividend increases; they more often, and more quickly, rise if the stock price falls. And that, in turn, means that many high-yield stocks aren’t performing all that well at the moment — and may have reasonably significant risks going forward.
Paylocity Holding (PCTY - Free Report) has an impressive earnings surprise history, having surpassed the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average positive surprise of 220.1%. With expected long-term earnings per share growth rate of 22% and a market cap of $3.03 billion, it seems to be a stock that investors need to retain in their portfolio if they are looking to reap long-term gains.
We are at the tail end of the first-quarter earnings season. The current reporting cycle is on track to record the strongest growth in the past seven years. Total earnings are expected to be up 23.6% on revenue growth of 8.8%, per the latest Earnings Outlook report. This is much higher than 13.4% earnings growth and 8.1% revenue growth recorded in Q4.
We are at the tail end of the first-quarter earnings season. The current reporting cycle is on track to record the strongest growth in the past seven years. Total earnings are expected to be up 23.6% on revenue growth of 8.8%, per the latest Earnings Outlook report. This is much higher than 13.4% earnings growth and 8.1% revenue growth recorded in Q4. The bullish projection for the quarter have been attributed to factors like the corporate tax overhaul apart from an improving economy and a much-improved job market.
The Dun & Bradstreet Corporation (DNB - Free Report) is slated to report first-quarter 2018 results on May 9, after market close.
46 of 52 Nasdaq Index dividends were presumed "safer" because they showed positive one-year returns and free cash flow yields greater than dividend yields as of 5/4/17.
"The Nasdaq-100 Index includes 100 of the largest domestic and international non-financial companies listed on The Nasdaq Stock Market based on market capitalization." 52 pay dividends.
In January, I began publishing articles that examined how far several large-cap industrial and service stocks might fall during a bear market, and I suggested some alternative investments.
Stericycle, Inc. (SRCL - Free Report) is slated to report first-quarter 2018 results on May 3, after market close.
I like monitoring dividend increases for stocks on my watch list of dividend growth stocks because I consider such stocks to be candidates for further analysis.
We often lose sight of these things once we’re in the thick of earnings season, like we are now, but this happens to be Jobs Week. With the Automatic Data Processing (ADP - Free Report) private-sector report coming out for the month of April tomorrow, and the all-important Bureau of Labor Statistics (BLS) non-farm payroll report on Friday. But on CNBC’s Squawk Box this morning, Martin Mucci of Paychex, Inc.
Tuesday, May 1, 2018 We often lose sight of these things once we’re in the thick of earnings season, like we are now, but this happens to be Jobs Week. With the Automatic Data Processing (ADP - Free Report) private-sector report coming out for the month of April tomorrow, and the all-important Bureau of Labor Statistics (BLS) non-farm payroll report on Friday. But on CNBC’s Squawk Box this morning, Martin Mucci of Paychex, Inc.
PAYX-8K-042618 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Rising bond yields and concerns over peaking earnings were enough to cause the S&P 500 Index to largely stagnate last week. However, a handful of leading businesses expressed optimism in the form of dividend boosts.
* PAYCHEX INC - DIRECTORS VOTED TO EXPAND BOARD TO 11 MEMBERS Source text for Eikon: Further company coverage:
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET